Trial Profile
A Single-Blind, Randomized, Placebo Controlled, Rising Multiple Dose, Safety, Tolerability and Pharmacokinetic Study of RBx 10017609 in Healthy Adult Male Human Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs RBx 10017609 (Primary)
- Indications Obstructive airway disorders
- Focus Adverse reactions
- 04 Jul 2012 Status changed from recruiting to completed as reported by Clinical Trials Registry - India.
- 24 Jun 2009 New trial record